Port Washington, NY – September 28, 2018

Drive DeVilbiss Healthcare announced today that members of its clinical support team will discuss topics currently affecting the DME industry at Medtrade in Atlanta on October 15 and 17. These topics include importance of DME access for the long-term care community, differentiating your brand through improved clinical outcomes, and the benefit of oxygen modalities.

On October 15 at 3:15 p.m., Karen Lerner, RN, MSN, ATP and CWS, Regional VP of Pressure Prevention; Tony Crisitello, Senior VP of Long-Term Care; and other industry experts will speak at the session titled, “Get into the Stretch Zone: Why Aren’t You Renting and Selling to Your local LTC and SNFs?” This session will cover the importance of the long-term care community having access to DME. This access will provide improved mental and physical health, ambulation, comfort and welfare for residents.

On October 17 at 9 a.m., panelists Daniel O’Malley, Regional VP of Pressure Prevention Sales; John Zelczak, BS, RRT, CPFT, Regional VP of Respiratory Sales; moderator Karen Lerner; and other industry experts will cover how to differentiate your brand and gain business by influencing clinical outcomes in the session entitled “Become a Triple Threat: Driving Down Cost While Improving Clinical Outcomes and Patient Satisfaction.” The speakers will discuss learning the cost and benefit of becoming consultative partners to referrals and payors.

“The conference panel discussions are a value-added benefit for both the attendee and the panel hosts,” Lerner said. “The transfer of knowledge that occurs enables the panel experts to understand the needs of the industry, and the attendees to understand the available solutions that will improve patient outcomes.”

On October 17 at 1:30 p.m., panelists Joe Lewarski, MHA, RRT, FAARC, SVP/GM Global Business-Clinical Care; Mitch Yoel, SVP of Global Commercial Operations; David Pugh, Regional VP of Respiratory Sales; moderator Vanessa Saltmarsh, VP of Clinical Services; and other industry experts will cover the benefits and trade-offs of current oxygen modalities with key industry stakeholders. During the session entitled, “Putting ‘Care’ Back in HomeCare: Optimizing Oxygen Modality Selection”, they will discuss the best practices in balancing patient wants, improving operational expenses and securing positive clinical outcomes.

At Medtrade booth 1909, Drive DeVilbiss Healthcare will also highlight its vast product selection, exceptional customer service and financing solutions that enable providers to offer their customers a wide array of solutions to improve their quality of life.

For more information on the full line of Drive DeVilbiss products, visit www.drivemedical.com or contact your Sales Representative to learn more about the Medtrade Specials.

About Drive DeVilbiss Healthcare

Headquartered in Port Washington, New York, Drive DeVilbiss Healthcare manufactures a complete line of medical products, including mobility products, sleep and respiratory products, beds, bariatric products, wheelchairs, sleep surfaces and pressure prevention products, self‐assist products, power For Immediate Release operated wheelchairs, rehabilitation products, resident room equipment, personal care products and electrotherapy devices. Currently, the Company has corporate offices, manufacturing facilities and distribution facilities located throughout the United States, Canada, the United Kingdom, France, Germany, China, Hong Kong, Romania, Australia, the Netherlands and India. The Company markets its products to customers located throughout the United States, Europe, Canada, Mexico, Central and South America, the Middle East and Asia. For more information, visit www.drivemedical.com.

Contact:

Drive DeVilbiss Healthcare
Stephanie K. Murray
Marketing Communications Manager
Email: SMurray@DriveMedical.com
Tel: (814) 443‐7658